UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:CASC3-ACLY |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: CASC3-ACLY | FusionPDB ID: 13141 | FusionGDB2.0 ID: 13141 | Hgene | Tgene | Gene symbol | CASC3 | ACLY | Gene ID | 22794 | 47 |
Gene name | CASC3 exon junction complex subunit | ATP citrate lyase | |
Synonyms | BTZ|MLN51 | ACL|ATPCL|CLATP | |
Cytomap | 17q21.1 | 17q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | protein CASC3MLN 51barentszcancer susceptibility 3cancer susceptibility candidate 3cancer susceptibility candidate gene 3 proteinmetastatic lymph node 51metastatic lymph node gene 51 proteinprotein barentsz | ATP-citrate synthaseATP-citrate (pro-S-)-lyasecitrate cleavage enzyme | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | O15234 | P53396 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000264645, | ENST00000588779, ENST00000352035, ENST00000353196, ENST00000393896, ENST00000537919, ENST00000590151, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 21 X 10 X 10=2100 | 13 X 13 X 6=1014 |
# samples | 28 | 15 | |
** MAII score | log2(28/2100*10)=-2.90689059560852 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1014*10)=-2.75702324650746 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CASC3 [Title/Abstract] AND ACLY [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CASC3(38324670)-ACLY(40024157), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | CASC3-ACLY seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CASC3-ACLY seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CASC3-ACLY seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CASC3-ACLY seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CASC3-ACLY seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. CASC3-ACLY seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. CASC3-ACLY seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CASC3 | GO:0000398 | mRNA splicing, via spliceosome | 29301961 |
Tgene | ACLY | GO:0006085 | acetyl-CoA biosynthetic process | 1371749 |
Tgene | ACLY | GO:0006101 | citrate metabolic process | 1371749 |
Tgene | ACLY | GO:0006107 | oxaloacetate metabolic process | 1371749 |
Tgene | ACLY | GO:0008610 | lipid biosynthetic process | 23932781 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-R5-A7ZE-01B | CASC3 | chr17 | 38324670 | + | ACLY | chr17 | 40024157 | - |
ChimerDB4 | STAD | TCGA-R5-A7ZE | CASC3 | chr17 | 38324670 | + | ACLY | chr17 | 40024157 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000264645 | CASC3 | chr17 | 38324670 | + | ENST00000590151 | ACLY | chr17 | 40024157 | - | 3179 | 2191 | 172 | 2217 | 681 |
ENST00000264645 | CASC3 | chr17 | 38324670 | + | ENST00000353196 | ACLY | chr17 | 40024157 | - | 3165 | 2191 | 172 | 2217 | 681 |
ENST00000264645 | CASC3 | chr17 | 38324670 | + | ENST00000537919 | ACLY | chr17 | 40024157 | - | 2640 | 2191 | 172 | 2217 | 681 |
ENST00000264645 | CASC3 | chr17 | 38324670 | + | ENST00000393896 | ACLY | chr17 | 40024157 | - | 2522 | 2191 | 172 | 2217 | 681 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000264645 | ENST00000590151 | CASC3 | chr17 | 38324670 | + | ACLY | chr17 | 40024157 | - | 0.001680343 | 0.9983197 |
ENST00000264645 | ENST00000353196 | CASC3 | chr17 | 38324670 | + | ACLY | chr17 | 40024157 | - | 0.001610357 | 0.9983897 |
ENST00000264645 | ENST00000537919 | CASC3 | chr17 | 38324670 | + | ACLY | chr17 | 40024157 | - | 0.006746597 | 0.9932534 |
ENST00000264645 | ENST00000393896 | CASC3 | chr17 | 38324670 | + | ACLY | chr17 | 40024157 | - | 0.008144006 | 0.991856 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >13141_13141_1_CASC3-ACLY_CASC3_chr17_38324670_ENST00000264645_ACLY_chr17_40024157_ENST00000353196_length(amino acids)=681AA_BP= MRRARCVSTSPVVAVLRKMADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSA EESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKV GKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDD IKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGRAGFRPVEAGGQHGGRSGET VKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVKLAEEVPPPPEGLI PAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRY SSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPP -------------------------------------------------------------- >13141_13141_2_CASC3-ACLY_CASC3_chr17_38324670_ENST00000264645_ACLY_chr17_40024157_ENST00000393896_length(amino acids)=681AA_BP= MRRARCVSTSPVVAVLRKMADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSA EESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKV GKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDD IKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGRAGFRPVEAGGQHGGRSGET VKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVKLAEEVPPPPEGLI PAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRY SSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPP -------------------------------------------------------------- >13141_13141_3_CASC3-ACLY_CASC3_chr17_38324670_ENST00000264645_ACLY_chr17_40024157_ENST00000537919_length(amino acids)=681AA_BP= MRRARCVSTSPVVAVLRKMADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSA EESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKV GKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDD IKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGRAGFRPVEAGGQHGGRSGET VKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVKLAEEVPPPPEGLI PAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRY SSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPP -------------------------------------------------------------- >13141_13141_4_CASC3-ACLY_CASC3_chr17_38324670_ENST00000264645_ACLY_chr17_40024157_ENST00000590151_length(amino acids)=681AA_BP= MRRARCVSTSPVVAVLRKMADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSA EESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKV GKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDD IKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGRAGFRPVEAGGQHGGRSGET VKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVKLAEEVPPPPEGLI PAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRY SSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPP -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:38324670/chr17:40024157) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CASC3 | ACLY |
FUNCTION: Required for pre-mRNA splicing as component of the spliceosome (PubMed:28502770, PubMed:29301961). Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Stimulates the ATPase and RNA-helicase activities of EIF4A3. Plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. Component of the dendritic ribonucleoprotein particles (RNPs) in hippocampal neurons. May play a role in mRNA transport. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Binds poly(G) and poly(U) RNA homopolymer. {ECO:0000269|PubMed:17375189, ECO:0000269|PubMed:17652158, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961}. | FUNCTION: Catalyzes the cleavage of citrate into oxaloacetate and acetyl-CoA, the latter serving as common substrate for de novo cholesterol and fatty acid synthesis. {ECO:0000269|PubMed:10653665, ECO:0000269|PubMed:1371749, ECO:0000269|PubMed:19286649, ECO:0000269|PubMed:23932781, ECO:0000269|PubMed:9116495}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 95_131 | 655.0 | 1130.6666666666667 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 392_395 | 655.0 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 41_46 | 655.0 | 1130.6666666666667 | Compositional bias | Note=Poly-Gly |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 425_428 | 655.0 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 643_648 | 655.0 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 204_210 | 655.0 | 1130.6666666666667 | Motif | Nuclear localization signal 1 |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 254_262 | 655.0 | 1130.6666666666667 | Motif | Nuclear localization signal 2 |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 462_466 | 655.0 | 1130.6666666666667 | Motif | Note=Nuclear export signal |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 137_283 | 655.0 | 1130.6666666666667 | Region | Note=Sufficient to form the EJC |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 692_695 | 655.0 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro |
Hgene | CASC3 | chr17:38324670 | chr17:40024157 | ENST00000264645 | + | 11 | 14 | 377_703 | 655.0 | 1130.6666666666667 | Region | Note=Necessary for localization in cytoplasmic stress granules |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000352035 | 27 | 29 | 4_265 | 1070.3333333333333 | 1102.0 | Domain | Note=ATP-grasp | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000353196 | 26 | 28 | 4_265 | 1060.3333333333333 | 1092.0 | Domain | Note=ATP-grasp | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000393896 | 26 | 28 | 4_265 | 1060.3333333333333 | 1092.0 | Domain | Note=ATP-grasp | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000590151 | 27 | 29 | 4_265 | 1070.3333333333333 | 1102.0 | Domain | Note=ATP-grasp | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000352035 | 27 | 29 | 109_111 | 1070.3333333333333 | 1102.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000352035 | 27 | 29 | 66_67 | 1070.3333333333333 | 1102.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000352035 | 27 | 29 | 701_721 | 1070.3333333333333 | 1102.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000352035 | 27 | 29 | 752_778 | 1070.3333333333333 | 1102.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000353196 | 26 | 28 | 109_111 | 1060.3333333333333 | 1092.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000353196 | 26 | 28 | 66_67 | 1060.3333333333333 | 1092.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000353196 | 26 | 28 | 701_721 | 1060.3333333333333 | 1092.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000353196 | 26 | 28 | 752_778 | 1060.3333333333333 | 1092.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000393896 | 26 | 28 | 109_111 | 1060.3333333333333 | 1092.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000393896 | 26 | 28 | 66_67 | 1060.3333333333333 | 1092.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000393896 | 26 | 28 | 701_721 | 1060.3333333333333 | 1092.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000393896 | 26 | 28 | 752_778 | 1060.3333333333333 | 1092.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000590151 | 27 | 29 | 109_111 | 1070.3333333333333 | 1102.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000590151 | 27 | 29 | 66_67 | 1070.3333333333333 | 1102.0 | Nucleotide binding | Note=ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000590151 | 27 | 29 | 701_721 | 1070.3333333333333 | 1102.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000590151 | 27 | 29 | 752_778 | 1070.3333333333333 | 1102.0 | Nucleotide binding | ATP | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000352035 | 27 | 29 | 779_789 | 1070.3333333333333 | 1102.0 | Region | CoA-binding | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000353196 | 26 | 28 | 779_789 | 1060.3333333333333 | 1092.0 | Region | CoA-binding | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000393896 | 26 | 28 | 779_789 | 1060.3333333333333 | 1092.0 | Region | CoA-binding | |
Tgene | ACLY | chr17:38324670 | chr17:40024157 | ENST00000590151 | 27 | 29 | 779_789 | 1070.3333333333333 | 1102.0 | Region | CoA-binding |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>1402_CASC3_38324670_ACLY_40024157_ranked_0.pdb | CASC3 | 38324670 | 38324670 | ENST00000393896 | ACLY | chr17 | 40024157 | - | MRRARCVSTSPVVAVLRKMADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSA EESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKV GKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDD IKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGRAGFRPVEAGGQHGGRSGET VKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVKLAEEVPPPPEGLI PAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRY SSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPP | 681 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
CASC3_pLDDT.png![]() |
ACLY_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
CASC3 | |
ACLY |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CASC3-ACLY |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CASC3-ACLY |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |